An effective approach for treating elderly patients with isolated systolic hypertension: Results of an Italian multicenter study with fosinopril

American Journal of Hypertension

Volumn 10, Issue 10 II SUPPL., 1997, Pages

  Leonetti, Gastone ^a   Trimarco, Bruno ^b   Collatina, Stefano ^c   Tosetti, Alessandro ^d  

^a ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^b Università Secondo Ateneo di Napoli   (Italy)

^c BRISTOL MYERS SQUIBB   (United States)

^d Menarini Ricerche SpA   (Italy)

Author keywords

Angiotensin converting enzyme inhibitors; Elderly patients; Fosinopril; Isolated systolic hypertension

Indexed keywords

CHLORTALIDONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FOSINOPRIL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION;

EID: 0030730635     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0895-7061(97)00328-2     Document Type: Article

References (15)

1. Kannel WB, McGee D, Gordon T. A general cardiovascular risk profile in the Framingham study. Am J Cardiol. 38:1976;46-51.
2. Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke and coronary heart disease Part 2: Short-term reductions in blood pressure: overview of randomised controlled trials . Lancet. 335:1990;827-838.
3. MacMahon S, Rodgers A. The effects of antihypertensive treatment on vascular disease reappraisal of the evidence . J Vasc Med Biol. 4:1993;265-271.
4. Chobanian AV: Arterial wall characteristics in hypertension and aging, in Amery A, Staessen J (eds): Handbook of Hypertension, Vol 12. Elsevier, Amsterdam: 1989, pp 8-23.
5. Colandrea MA, Friedman GD, Nichaman MZ, Lynd CN. Systolic hypertension in the elderly. Circulation. 41:1970;239-246.
6. Kannel WB, Dawber TR, McGee DL. Perspective on systolic hypertension the Framingham study . Circulation. 61:1980;1179-1187.
7. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension final results of the Systolic Hypertension in the Elderly Program (SHEP) . JAMA. 265:1991;3255-3264.
8. Van Hoof R, Thijs L, Staessen J, et al: Therapeutic trials in elderly hypertensives: meta-analysis and implications for daily practice, in Leonetti G, Cuspidi C (eds): Hypertension in the Elderly. Kluwer Academic Press, Dordrecht, the Netherlands, 1994, pp 71-90.
9. Dahlof B, Lindholm LH, Hansson L, et al. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet. 338:1991;1281-1285.
10. Medical Research Council trial of treatment of hypertension in older adults principal results . Br Med J. 304:1992;405-412.
11. Anderson RJ, Duchin KL, Gore RD, et al. Once daily fosinopril in the treatment of hypertension. Hypertension. 17:1991;636-648.
12. Pool JL. Antihypertensive effect of fosinopril, a new angiotensin-converting enzyme inhibitor findings of the fosinopril study group . Clin Ther. 12:1990;528-538.
13. Sytowsky PA, D'Agostino RB, Belanger AJ, Kannel WB. Secular trends in long-term sustained hypertension, long-term treatment and cardiovascular mortality the Framingham Heart Study 1950 to 1990 . Circulation. 93:1996;697-703.
14. 1993 guidelines for the management of mild hypertension memorandum from a WHO/ISH meeting . J Hypertens. 11:1993;905-918.
15. McCombs JS, Nichol MB, Newman CM, et al. The costs of interrupting antihypertensive drug therapy in a Medicaid population. Med Care. 9:1994;265-269.